Wacker MG - Search Results

1

Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.

Villa Nova M, Lin TP, Shanehsazzadeh S, Jain K, Ng SCY, Wacker R, Chichakly K, Wacker MG. Villa Nova M, et al. Among authors: wacker r, wacker mg. Front Digit Health. 2022 Feb 18;4:799341. doi: 10.3389/fdgth.2022.799341. eCollection 2022. Front Digit Health. 2022. PMID: 35252958 Free PMC article. Review.

2

Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufacture.

Villa Nova M, Janas C, Schmidt M, Ulshoefer T, Gräfe S, Schiffmann S, de Bruin N, Wiehe A, Albrecht V, Parnham MJ, Luciano Bruschi M, Wacker MG. Villa Nova M, et al. Among authors: wacker mg. Int J Pharm. 2015 Aug 1;491(1-2):250-60. doi: 10.1016/j.ijpharm.2015.06.024. Epub 2015 Jun 26. Int J Pharm. 2015. PMID: 26123822 Free article.

3

A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.

Nagpal S, Braner S, Modh H, Tan AXX, Mast MP, Chichakly K, Albrecht V, Wacker MG. Nagpal S, et al. Among authors: wacker mg. Eur J Pharm Biopharm. 2020 Aug;153:257-272. doi: 10.1016/j.ejpb.2020.06.004. Epub 2020 Jun 24. Eur J Pharm Biopharm. 2020. PMID: 32589926

4

Simulate SubQ: The Methods and the Media.

Li D, Chow PY, Lin TP, Cheow C, Li Z, Wacker MG. Li D, et al. Among authors: wacker mg. J Pharm Sci. 2023 Jun;112(6):1492-1508. doi: 10.1016/j.xphs.2021.10.031. Epub 2021 Oct 30. J Pharm Sci. 2023. PMID: 34728176 Review.

5

Biopredictive tools for the development of injectable drug products.

Villa Nova M, Gan K, Wacker MG. Villa Nova M, et al. Among authors: wacker mg. Expert Opin Drug Deliv. 2022 Jun;19(6):671-684. doi: 10.1080/17425247.2022.2081682. Epub 2022 Jun 1. Expert Opin Drug Deliv. 2022. PMID: 35603724

6

Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin.

Li Z, Kovshova T, Malinovskaya J, Knoll J, Shanehsazzadeh S, Osipova N, Chernysheva A, Melnikov P, Gelperina S, Wacker MG. Li Z, et al. Among authors: wacker mg. Int J Nanomedicine. 2024 Mar 5;19:2039-2056. doi: 10.2147/IJN.S440598. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38476274 Free PMC article.

7

Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection.

Gao GF, Ashtikar M, Kojima R, Yoshida T, Kaihara M, Tajiri T, Shanehsazzadeh S, Modh H, Wacker MG. Gao GF, et al. Among authors: wacker mg. J Control Release. 2021 Jan 10;329:372-384. doi: 10.1016/j.jconrel.2020.11.055. Epub 2020 Nov 30. J Control Release. 2021. PMID: 33271202

8

Nanomedicine at the crossroads - A quick guide for IVIVC.

Mast MP, Modh H, Champanhac C, Wang JW, Storm G, Krämer J, Mailänder V, Pastorin G, Wacker MG. Mast MP, et al. Among authors: wacker mg. Adv Drug Deliv Rev. 2021 Dec;179:113829. doi: 10.1016/j.addr.2021.113829. Epub 2021 Jun 24. Adv Drug Deliv Rev. 2021. PMID: 34174332 Review.

9

Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.

Wacker M, Chen K, Preuss A, Possemeyer K, Roeder B, Langer K. Wacker M, et al. Int J Pharm. 2010 Jun 30;393(1-2):253-62. doi: 10.1016/j.ijpharm.2010.04.022. Epub 2010 Apr 24. Int J Pharm. 2010. PMID: 20417701

10

Photosensitizer loaded HSA nanoparticles II: in vitro investigations.

Preuss A, Chen K, Hackbarth S, Wacker M, Langer K, Röder B. Preuss A, et al. Int J Pharm. 2011 Feb 14;404(1-2):308-16. doi: 10.1016/j.ijpharm.2010.11.023. Epub 2010 Nov 19. Int J Pharm. 2011. PMID: 21094228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page